Multi-Peptide Research Blends: Design and Documentation
Why laboratories use multi-component vials, how to calculate per-component concentration after reconstitution, and what a blend's documentation must show.
Why blends exist in a research setting
A blend vial contains two or more peptides lyophilized together at a fixed mass ratio. In study designs that examine several signaling pathways in parallel, a blend reduces the number of reconstitutions, the number of vials tracked in inventory, and the number of independent dilution errors that can enter an experiment.
The tradeoff is flexibility: the ratio is fixed at manufacture. When a protocol needs to vary one component independently, single-compound vials remain the correct choice. Blends suit screening and parallel-pathway work; single vials suit dose–response work on one target.
Calculating per-component concentration
Total vial mass is not the working number. For a 70MG blend of 10MG + 10MG + 50MG reconstituted in 2 mL of bacteriostatic water, the solution is 5 mg/mL of the first component, 5 mg/mL of the second, and 25 mg/mL of the third — never 35 mg/mL of a single thing.
Record all three figures on the vial label alongside the reconstitution date. Documenting only the total mass is the most common source of unreproducible results with blended material.
Documentation to require per lot
A blend's certificate of analysis should identify each component separately, with purity by HPLC and identity confirmed by mass spectrometry, and it should be tied to the lot number printed on the vial. A single aggregate purity number for a multi-component vial is not interpretable.
Also confirm buffer compatibility before assay work. Copper-binding peptides in particular can interact with common buffer components, which is a compatibility question for your assay rather than a quality problem with the material.
References
These products are sold strictly for in-vitro laboratory research and are not intended for human consumption, diagnosis, treatment, or any therapeutic use. Purchaser must be 18 years of age or older and confirms they are a qualified researcher.